These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181 [TBL] [Abstract][Full Text] [Related]
6. Vaccination against human cytomegalovirus with live virus. Plotkin SA; Friedman HM; Starr S; Fleisher G Dev Biol Stand; 1982; 52():373-9. PubMed ID: 6299846 [No Abstract] [Full Text] [Related]
7. Cytomegalovirus vaccines: current status. Starr SE Infect Agents Dis; 1992 Jun; 1(3):146-8. PubMed ID: 1365538 [TBL] [Abstract][Full Text] [Related]
8. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376 [TBL] [Abstract][Full Text] [Related]
9. Progress toward developing a cytomegalovirus vaccine. Marshall GS; Plotkin SA Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034 [TBL] [Abstract][Full Text] [Related]